Program Chairperson Gordon B. Mills, M.D., Ph.D., chair of the department of systems biology at the University of Texas MD Anderson Cancer Center hosted a press conference on some of the new diagnostic methods under development on Sept. 28, at 1:00 p.m. MT.
ROCKVILLE, Md., Sept. 29 /- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage biopharmaceutical company, announced today that Mr. Frederick Driscoll, Chief Financial Officer of Novavax, will be presenting at the BIO Investor Forum. The presentation will take place on Wednesday, October 6,...
PositiveID Corporation Withdraws Offer to Purchase All Outstanding Shares of Digital Angel CorporationSeptember 29, 2010 8:33 am | by PositiveID | News | Comments
PositiveID Corporation Withdraws Offer to Purchase All Outstanding Shares of Digital Angel Corporation
CPSC and FDA Warn Against Using Infant Sleep Positioners Because of Suffocation Risk: Initial CommunicationSeptember 29, 2010 8:31 am | by U.S. Food & Drug Administration | News | Comments
The FDA and the CPSC are aware of 12 infant deaths in the past 13 years associated with the use of infant sleep positioners. Deaths occurred after the baby rolled from its back onto its stomach and became trapped and suffocated between the device and...
DEARBORN, Mich., September 28, 2010 — Three fully-functional, state-of-the-art stamping lines will be featured in action at the booths of AIDA, SEYI and Stamtec in the METALFORM Technology Area of the 2010 FABTECH show in Atlanta, Nov. 2-4. More
DEARBORN, Mich., September 28, 2010 — As the U.S. ramps up efforts to improve STEM (Science, Technology, Engineering and Manufacturing) education, the SME Education Foundation is building on its 30-year record of advancing technology-based education with the selection of its 2011...
MUMBAI, India, Sept. 29 /- Sun Pharmaceutical Industries Ltd. (Sun) (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced the expiration of the subsequent offering period to the tender offer by Sun's subsidiary Alkaloida Chemical Company Exclusive Group Ltd...
While refining their novel method for making nanoscale wires, chemists at the National Institute of Standards and Technology (NIST) discovered an unexpected bonus?a new way to create nanowires that produce light similar to that from light-emitting diodes (LEDs).
MOUNTAIN VIEW, Calif., Sept. 29 /- AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Benrikal Services to distribute the Bengal Radial Compression Band in the United States. The Bengal, uniquely designed for...
(NIH/National Institute of Neurological Disorders and Stroke) The NINDS has established two new sites as part of the Morris K. Udall Centers of Excellence in Parkinson's Disease Research: Emory University in Atlanta and the Feinstein Institute for Medical Research in Manhasset, N.Y.
Exclusive cooperation agreement for advanced nanoceramic technology used in power plants
Ahead of a regulatory review next year, the Belgian EU Presidency is proposing to create a specific register for nanomaterials under the bloc's REACH chemicals regulation and wants to make it mandatory to label their presence in consumer products.
(University of Michigan) Twelve years ago, then 28-year-old graduate student Brian Zikmund-Fisher was forced into the toughest choice of his life: Die from a blood disorder within a few years or endure a bone marrow transplant that could cure him or kill him in weeks.
<i>From the Bench: </i>Alfama shows carbon monoxide can be therapeutic, if they can deliver itSeptember 28, 2010 8:34 pm | by Mass High Tech: The Journal of New England Technology | News | Comments
Alfama Inc. sees carbon monoxide as a therapy for a significant number of medical conditions, including liver failure, rheumatoid arthritis, heart attack and gastric ulcers. The trick is in delivering CO to the disease site without causing the problems that most people associate with the gas.
DENVER — A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.